You have 9 free searches left this month | for more free features.

e2609

Showing 1 - 10 of 10

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Alzheimer, Dementia, Alzheimer Type Trial in United States (E2609, Placebo)

Terminated
  • Alzheimer Disease
  • Dementia, Alzheimer Type
  • E2609
  • Placebo
  • Bellflower, California
  • +20 more
Mar 4, 2021

Early Alzheimer's Disease Trial in Miami, Orlando, Minneapolis (E2609)

Completed
  • Early Alzheimer's Disease
  • E2609
  • Miami, Florida
  • +2 more
Jun 7, 2017

Healthy Participants Trial in Fukuoka (E2609, Placebo)

Completed
  • Healthy Participants
  • E2609
  • Placebo
  • Fukuoka, Japan
    Eisai Trial Site
Apr 14, 2017

Alzheimer's Disease Trial in Glendale, Baltimore (E2609, Placebo for E2609)

Completed
  • Alzheimer's Disease
  • E2609
  • Placebo for E2609
  • Glendale, California
  • +1 more
Dec 29, 2016

Metabolism and Elimination Trial in Madison (E2609)

Completed
  • Metabolism and Elimination
  • E2609
  • Madison, Wisconsin
  • +1 more
Jan 6, 2016

Healthy Trial in Orlando (E2609, Placebo)

Completed
  • Healthy
  • E2609
  • Placebo
  • Orlando, Florida
    Compass Research Phase 1, LLC
Nov 2, 2015

Healthy Subjects Trial in San Antonio (Placebo, E2609, Moxifloxacin)

Completed
  • Healthy Subjects
  • Placebo
  • +2 more
  • San Antonio, Texas
    (unnamed)
Nov 2, 2015

Healthy Subjects Trial in San Antonio (E2609, itraconazole, rifampin)

Completed
  • Healthy Subjects
  • E2609
  • +4 more
  • San Antonio, Texas
    WCT Early Development
Nov 2, 2015

Healthy Subjects Trial in Glendale (E2609, Placebo)

Completed
  • Healthy Subjects
  • E2609
  • Placebo
  • Glendale, California
    (unnamed)
Nov 2, 2015

Alzheimer's Disease Trial in Glendale (E2609)

Completed
  • Alzheimer's Disease
  • E2609
  • Glendale, California
    California Clinical Trials/Parexel
May 20, 2013